Skip to main content
. 2014 Apr;58(4):2356–2362. doi: 10.1128/AAC.02661-13

FIG 3.

FIG 3

Multidose exposure-efficacy relationship of amphotericin B against each Aspergillus species with modal CLSI MICs of 1 mg/liter for A. fumigatus, A. flavus, and A. terreus in the in vitro PK-PD model simulating amphotericin B human serum levels based on the increasing amphotericin B fCmax (maximum concentration) and the galactomannan index as a marker of fungal growth.